Our analysis showed a higher expression of ULBP2 in individuals with cancer, and increased expression of ULPB2 was correlated with poorer survival, indicating that ULBP2 acts as an NK-cell inhibitor in cervical cancer. The gene discussed is ULBP2; the disease is cervical cancer.